Fig. 2From: Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutated, non-small cell lung cancerKaplan-Meier curves for recurrence-free survival (A, B) and overall survival (C, D) according to pretreatment T790M status (high vs low). (A) and (C) for the population with pathological stage IA NSCLC. (B) and (D) for the population with pathological stage IB-IV NSCLC. Plus signs denote censoringBack to article page